TAF9 anticorps (AA 1-264)

N° du produit ABIN7172703

L’anticorps Lapin Polyclonal anti-TAF9 a été validé pour WB, ELISA et IHC. Il convient pour détecter TAF9 dans des échantillons de Humain.

Aperçu rapide pour TAF9 anticorps (AA 1-264) (ABIN7172703)

Antigène: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TAF9 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-TAF9 anticorps

Épitope: AA 1-264

Réactivité croisée: Humain

Purification: Antigen Affinity Purified

Immunogène: Recombinant Human Transcription initiation factor TFIID subunit 9 protein (1-264AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur TAF9

Antigène: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Autre désignation: TAF9

Sujet:

Background: Component of TFIID, the TATA-binding protein-free TAF complex (TFTC), the PCAF complex and the STAGA transcription coactivator-HAT complex. The PCAF complex consists at least of TADA2L/ADA2, SUPT3H/SPT3, TADA3L/ADA3, TAF5L/PAF65-beta, TAF6L/PAF65-alpha, TAF10/TAFII30, TAF12/TAFII20, TAF9/TAFII31 and TRRAP. The STAGA transcription coactivator-HAT complex consists at least of SUPT3H, GCN5L2, SUPT7L, TAF5L, TAF6L, TADA3L, TAD1L, TAF10, TAF12, TRRAP and TAF9. Binds N-terminal domain of p53/TP53 which is essential for transcription. Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Binds TFIIB and the Herpes simplex virus activator VP16. Forms a heterodimer with TAF6/TAFII80 in a complex with the TAF4B/TAFII105-TAF12/TAFII20 heterodimer. Also interacts with TAF5. Binds directly DNA. Increased DNA binding when complexed with TAF6/TAFII80.

Aliases: TAF9 antibody, TAF2G antibody, TAFII31 antibody, Transcription initiation factor TFIID subunit 9 antibody, RNA polymerase II TBP-associated factor subunit G antibody, STAF31/32 antibody, Transcription initiation factor TFIID 31 kDa subunit antibody, TAFII-31 antibody, TAFII31 antibody, Transcription initiation factor TFIID 32 kDa subunit antibody, TAFII-32 antibody, TAFII32 antibody

UniProt: Q16594

Pathways: Negative Regulation of intrinsic apoptotic Signaling